Amino-alcohol compounds and their use in therapy

Amino-alcohol compounds are developed to disrupt the YAP/TAZ-TEAD complex, addressing the need for Hippo signaling pathway modulators to treat cancers and fibrosis-related diseases by effectively targeting the complex.

WO2026125505A1PCT designated stage Publication Date: 2026-06-18INVENTIVA

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
INVENTIVA
Filing Date
2025-12-10
Publication Date
2026-06-18

AI Technical Summary

Technical Problem

There is a need for modulators of the Hippo signaling pathway to disrupt the YAP/TAZ-TEAD complex, which is involved in organ development and amplification of oncogenic factors in various cancers and fibrosis-related diseases.

Method used

Development of amino-alcohol compounds that modulate the YAP/TAZ-TEAD complex by disrupting its interaction, which are used in pharmaceutical compositions for treating or preventing cancers and fibrosis-related diseases.

Benefits of technology

The compounds effectively target the YAP/TAZ-TEAD complex, providing therapeutic benefits in treating or preventing a range of cancers and fibrosis-related diseases.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IMGF000002_0001
    Figure IMGF000002_0001
  • Figure IMGF000004_0001
    Figure IMGF000004_0001
  • Figure IMGF000023_0001
    Figure IMGF000023_0001
Patent Text Reader

Abstract

The present disclosure relates to compounds of formula (I): (I) wherein A, W, X, Y, Z, R1, R2, R3 , R4 , R5 , R'5 , R6 , R'6 , R7 , R8 and R9 are as defined herein. The compounds of formula (I) are useful as modulators of the Hippo signaling pathway.
Need to check novelty before this filing date? Find Prior Art